GPX4 and neoplasm: However, the therapeutic potential of both pathways is significantly hindered by the tumor microenvironment (TME), where elevated levels of GSH and GPX4 efficiently neutralize reactive oxygen species (ROS) and lipid peroxides, thereby attenuating ferroptosis and cuproptosis [22,23].